| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
SUPPLEMENT |
From the Section of Thoracic Surgery, Evanston Northwestern Healthcare, Evanston, Illinois.
Correspondence: Address correspondence and reprint requests to: Michael J. Liptay, MD, Section of Thoracic Surgery, Evanston Northwestern Healthcare, Burch 100, 2650 Ridge Avenue, Evanston, IL 60201; Fax: 847-570-2899; E-mail: m-liptay{at}nwu.edu
ABSTRACT
Lymph node metastases are the most significant prognostic factor in localized non-small-cell lung cancer (NSCLC). Nodal micrometastases may not be detected with current standard histologic methods. We review our experience with intraoperative injection of radioisotope, the current state of the technique, and the experience of other groups with alternate methods and tracers.
Key Words: Lung cancer Lymph node metastases Sentinal node mapping
This article has been cited by other articles:
![]() |
M. J. Liptay Sentinel Node Mapping in Lung Cancer: The Holy Grail? Ann. Thorac. Surg., February 1, 2008; 85(2): S778 - S779. [Full Text] [PDF] |
||||
![]() |
A. Meyer, C. Cheng, C. Antonescu, E. Pezzetta, A. Bischof-Delaloye, and H.-B. Ris Successful migration of three tracers without identification of sentinel nodes during intraoperative lymphatic mapping for non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 214 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Liptay In Vivo Sentinel Lymph Node Mapping in Lung Cancer Ann. Surg. Oncol., February 1, 2005; 12(2): 102 - 103. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |